Praxis Precision Medicines

PRAXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.058 B

$360.76 -2.54%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$303.0M

Loss-making

Shares outstanding

27,919,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#35Axsome TherapeuticsAXSM$10.9B
#36Dr Reddys LaboratoriesRDY$10.2B
#37Praxis Precision MedicinesPRAX$10.1B
#38CytokineticsCYTK$9.55B
#39Protagonist TherapeuticsPTGX$9.44B

Where these numbers come from

Share counts and financials for Praxis Precision Medicines are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.